Compare CRNX & WHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRNX | WHR |
|---|---|---|
| Founded | 2008 | 1911 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Consumer Electronics/Appliances |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 3.7B |
| IPO Year | 2018 | 1994 |
| Metric | CRNX | WHR |
|---|---|---|
| Price | $33.81 | $51.47 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 7 |
| Target Price | $74.78 | ★ $82.00 |
| AVG Volume (30 Days) | 1.1M | ★ 2.7M |
| Earning Date | 05-07-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 6.93% |
| EPS Growth | N/A | ★ 196.42 |
| EPS | N/A | ★ 5.66 |
| Revenue | $1,039,000.00 | ★ $21,253,000,000.00 |
| Revenue This Year | $722.66 | $0.01 |
| Revenue Next Year | $183.79 | $3.46 |
| P/E Ratio | ★ N/A | $9.17 |
| Revenue Growth | N/A | ★ 2.58 |
| 52 Week Low | $24.10 | $51.69 |
| 52 Week High | $57.99 | $111.96 |
| Indicator | CRNX | WHR |
|---|---|---|
| Relative Strength Index (RSI) | 29.93 | 26.75 |
| Support Level | $33.23 | N/A |
| Resistance Level | $37.23 | $80.65 |
| Average True Range (ATR) | 1.57 | 2.02 |
| MACD | 0.09 | 0.43 |
| Stochastic Oscillator | 13.27 | 8.04 |
Crinetics Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its main product, Palsonify (paltusotine), is a once-daily, oral treatment approved by the FDA for adults with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option. Additionally, the company's development pipeline includes several programs, including a late-stage investigational candidate, atumelnant, currently in development for CAH and ADCS, and CRN09682, a NDC candidate that is being developed to treat SST2-expressing NETs and other SST2-expressing solid tumors.
Whirlpool Corp is a manufacturer and marketer of kitchen and laundry appliances, with its presence in different markets around the world. It offers products like refrigerators, washing machines, cooktops, ovens, freezers, and others, which are marketed through various brands such as KitchenAid, Maytag, Amana, Brastemp, Consul, Whirlpool, Jennair, etc. The company's operating and reportable segments are: Major Domestic Appliances (MDA) North America (its key revenue-generating segment), MDA Europe, MDA Latin America, and Small Domestic Appliances (SDA) Global.